Pacific Biosciences of California logo
PACBPacific Biosciences of California
Trade PACB now
Pacific Biosciences of California primary media

About Pacific Biosciences of California

Pacific Biosciences of California (NASDAQ:PACB) specializes in developing and manufacturing advanced sequencing technologies that empower scientists and researchers around the world to tackle genetically complex problems. Their standout product suite includes highly accurate long-read sequencing platforms, designed to facilitate the study of human, plant, and animal genomes and drive the discovery of novel insights in genetics. At the heart of their mission is the objective to enable the advancement of science and improve human health through innovation in DNA sequencing. With projects ranging from enhancing genomic research capabilities to partnerships aimed at solving specific scientific challenges, Pacific Biosciences is committed to pushing the boundaries of what's possible in genomics research and applications, tailoring their approach to meet the expanding needs of their global user community.

What is PACB known for?

Snapshot

Public US
Ownership
2004
Year founded
834
Employees
Menlo Park, United States
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Edison, US

Products and/or services of Pacific Biosciences of California

  • Sequel IIe System, enabling highly accurate long-read sequencing for genomics research.
  • HiFi sequencing, offering high-fidelity, long-read sequencing capabilities for genomic studies.
  • SMRT Link, a comprehensive software suite for sequencing data analysis and management.
  • Revio system, designed to significantly increase throughput and reduce costs for long-read genomic sequencing.
  • Onso, a new, highly accurate, long-read sequencing platform targeting clinical research applications.
  • SMRTbell Express Template Prep Kit 2.0, simplifying library preparation process for genomic sequencing.

Pacific Biosciences of California executive team

  • Mr. Christian O. Henry M.B.A.President, CEO & Director
  • Mr. Mark Van Oene Ph.D.Chief Operating Officer
  • Dr. Stephen Turner Ph.D.Co-Founder
  • Mr. James R. Gibson IIChief Financial Officer
  • Ms. Michele Farmer CPAVP & Chief Accounting Officer
  • Dr. Brett Atkins J.D., Ph.D.General Counsel & Corporate Secretary
  • Mr. David RuggieroGlobal Head of Sales & Service
  • Ms. Natalie WelchChief People Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.